Quantcast
Last updated on April 17, 2014 at 12:58 EDT

Latest antibodies Stories

2012-10-30 03:20:37

HASSELT, Belgium, October 30, 2012 /PRNewswire/ -- Complix announces that it has been awarded a EUR1.9 million grant (approximately USD$2.4 million) from the Flanders government through IWT (Agency for Innovation by Science and Technology in Flanders). The grant will allow Complix to accelerate the development of its unique cell penetrating Alphabodies (CPABs), against a range of intracellular disease targets, including cancer. Alphabodies represent a novel therapeutic...

2012-10-25 03:21:27

BREDA, the Netherlands and GHENT, Belgium, October 25, 2012 /PRNewswire/ -- arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody(TM) platform, has strengthened its supervisory board with the appointment of Dr. David L. Lacey. Dr. Lacey is a former Senior Vice President and Head of Discovery Research at Amgen with over 30 years of basic and clinical research experience. He played a...

Ancient Protein Preservation Confirmed In Dinosaur Bone Cells
2012-10-24 09:58:43

April Flowers for redOrbit.com - Your Universe Online A new study from North Carolina State University (NCSU) and the Palo Alto Research Center (PARC) reveals new evidence for the preservation of ancient dinosaur proteins. This new evidence includes reactivity to antibodies that target specific proteins that are normally found in bone cells of vertebrates. Further, the study findings rule out sample contamination, and solidify the case for the preservation of cells and possibly DNA in...

2012-10-23 07:28:23

ROCKVILLE, Md., Oct. 23, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of synthetic biologics and innovative medicines for serious diseases and unmet medical needs, announced today that Andrew Bristol, Ph.D., joined the team as its new Vice President of Research & Development. Dr. Bristol has over 20 years of experience in cancer research and drug development with a special emphasis on monoclonal antibodies and cancer vaccines. The Company also announced that...

2012-10-22 15:26:02

IRVINE, Calif., Oct. 22, 2012 /PRNewswire/ -- GeneTex Inc., a leading manufacturer of antibodies and antibody-related reagents, is set to launch a new antibody that can detect the oxidized form of calmodulin-dependent protein kinase II (CaMKII), which can be used to characterize and diagnose various diseases. (Logo: http://photos.prnewswire.com/prnh/20111129/LA13485LOGO-b) The activation of CaMKII through oxidation is associated with a variety of conditions including heart...

2012-10-19 01:40:44

Researchers Identify How Mosquito Immune System Attacks Specific Infections Researchers at the Johns Hopkins Bloomberg School of Public Health have determined a new mechanism by which the mosquitoes´ immune system can respond with specificity to infections with various pathogens, including the parasite that causes malaria in humans, using one single gene. Unlike humans and other animals, insects do not make antibodies to target specific infections. According to the Johns Hopkins...

2012-10-17 03:20:59

ZURICH-SCHLIEREN, Switzerland, Oct. 17, 2012 /PRNewswire/ -- Covagen announced today that it has entered into a strategic research collaboration and license agreement with Mitsubishi Tanabe Pharma Corporation (Osaka, Japan) and its fully owned subsidiary Tanabe Research Laboratories U.S.A., Inc. of San Diego Calif. (TRL). Under the agreement, Covagen will use its proprietary Fynomer-antibody platform to generate bispecific proteins (FynomAbs) against two target pairs selected...

2012-10-15 15:21:54

New in developmental research New research findings recently published in The FASEB Journal, show that immune system development is affected by gravity changes, as reported by researchers from the University of Lorraine and University of Luxembourg. Astronauts are exposed to stresses, during launch and landing, which disrupts their body's natural defenses against infection. Changes to the immune system need to be investigated before astronauts undergo longer space missions. Researchers...

2012-10-10 03:21:12

LONDON, Oct. 10, 2012 /PRNewswire/ -- Efficient resource to therapy of complex disorders with lesser side-effects has accelerated growth of monoclonal antibodies based therapeutics against conventional chemical drugs. However, high developmental costs constitute a major barrier for mid-segment market entrants. Growing market opportunities generated by innovative treatment methods and existing product success rate will boost market growth. New analysis from Frost & Sullivan, Analysis of...

2012-10-09 07:29:00

NEW YORK and GAITHERSBURG, Md., Oct. 9, 2012 /PRNewswire/ -- The Cancer Research Institute (CRI), the Ludwig Institute for Cancer Research and MedImmune, the global biologics arm of AstraZeneca, today announced that they have signed a collaboration agreement to advance the research of immunotherapy in cancer. Specifically, the research will focus on clinical trials to test novel combinations of immunotherapies, including three investigational monoclonal antibodies from MedImmune's pipeline....